logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

AACR 2018 — 2L avelumab for gastric/GEJ cancer fares well in JAVELIN update

Phase 1b data shows greater effect in chemotherapy-experienced vs -naive patients.